AI Engines For more Details: Perplexity Kagi Labs You
Saturated Fat and Cholesterol: Beef, especially fattier cuts, can be high in saturated fat and dietary cholesterol. Diets high in saturated fat and cholesterol have been linked to an increased risk of heart disease, stroke, and other cardiovascular conditions. Consuming large amounts of beef regularly may contribute to elevated blood cholesterol levels and worsen cardiovascular health, particularly if not balanced with other lean protein sources and plant-based foods.
Processed Beef Products: Some beef products, such as processed meats like sausages, hot dogs, and bacon, often contain added sodium, preservatives, and other additives. Regular consumption of processed meats has been associated with an increased risk of certain cancers, particularly colorectal cancer, as well as heart disease and other chronic conditions. Choosing unprocessed or minimally processed beef options is generally recommended for better health outcomes.
Environmental Impact: Beef production, particularly from conventional feedlot operations, can have significant environmental impacts, including greenhouse gas emissions, land degradation, water pollution, and biodiversity loss. Consuming large amounts of beef contributes to these environmental issues, as well as the unsustainable use of natural resources such as water and land. Choosing sustainably sourced beef or reducing beef consumption in favor of plant-based protein sources can help mitigate these environmental effects.
Digestive Health: Some individuals may experience digestive discomfort, bloating, or other gastrointestinal symptoms when consuming large amounts of beef, particularly if they have sensitivities or intolerances to certain components of meat, such as fat or protein. Moderating beef intake and diversifying protein sources may help alleviate these symptoms.
Antibiotic and Hormone Exposure: Conventionally raised beef cattle may be treated with antibiotics and growth hormones to promote growth and prevent disease. Regular consumption of conventionally produced beef may expose consumers to residues of these substances, which could have potential health implications, such as antibiotic resistance or disruption of hormonal balance. Choosing organic or grass-fed beef options may reduce exposure to antibiotics and hormones.
Rank | Probiotic | Impact |
---|---|---|
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Bifidobacterium pseudocatenulatum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 1.1 | 1 | 0.1 |
ADHD | 3 | 0.6 | 4 |
Allergic Rhinitis (Hay Fever) | 0.2 | 1.9 | -8.5 |
Allergies | 1.1 | 2.4 | -1.18 |
Allergy to milk products | 1.6 | -1.6 | |
Alopecia (Hair Loss) | 0.5 | -0.5 | |
Alzheimer's disease | 2.7 | 2 | 0.35 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.8 | 0.2 | 3 |
Ankylosing spondylitis | 1.1 | 0.8 | 0.38 |
Anorexia Nervosa | 1.4 | 0.2 | 6 |
Antiphospholipid syndrome (APS) | 0.2 | -0.2 | |
Asthma | 1.6 | 1.3 | 0.23 |
Atherosclerosis | 0.5 | 0.5 | |
Atrial fibrillation | 1.3 | 1.1 | 0.18 |
Autism | 2.1 | 2.7 | -0.29 |
Bipolar Disorder | 0.3 | 0.9 | -2 |
Brain Trauma | 1.6 | 0.2 | 7 |
Carcinoma | 1.1 | 1.1 | 0 |
Celiac Disease | 1.1 | 1.8 | -0.64 |
Cerebral Palsy | 1.1 | 1.1 | |
Chronic Fatigue Syndrome | 1.8 | 2.1 | -0.17 |
Chronic Kidney Disease | 0.5 | 0.6 | -0.2 |
Chronic Lyme | 0.6 | 0.6 | |
Chronic Urticaria (Hives) | 0.4 | 0.4 | |
Coagulation / Micro clot triggering bacteria | 0.6 | -0.6 | |
Colorectal Cancer | 1.1 | 2.5 | -1.27 |
Constipation | 2.1 | -2.1 | |
COVID-19 | 5.2 | 4.4 | 0.18 |
Crohn's Disease | 2.4 | 2 | 0.2 |
cystic fibrosis | 0.6 | 0.5 | 0.2 |
Depression | 4.5 | 3.3 | 0.36 |
Dermatomyositis | 0.3 | 0.5 | -0.67 |
Eczema | 0.2 | 1.6 | -7 |
Endometriosis | 0.9 | 1.1 | -0.22 |
Eosinophilic Esophagitis | 1.1 | 1.1 | |
Epilepsy | 1.4 | 1.8 | -0.29 |
Fibromyalgia | 0.8 | 0.7 | 0.14 |
Functional constipation / chronic idiopathic constipation | 2 | 3.6 | -0.8 |
gallstone disease (gsd) | 0.5 | -0.5 | |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.2 | -1.2 | |
Generalized anxiety disorder | 0.6 | 0.7 | -0.17 |
Gout | 0.6 | -0.6 | |
Graves' disease | 1.6 | 0.6 | 1.67 |
Halitosis | 0.8 | -0.8 | |
Hashimoto's thyroiditis | 1.1 | 1.1 | 0 |
Hidradenitis Suppurativa | 0.3 | 0.3 | |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.8 | 1.3 | -0.63 |
hypercholesterolemia (High Cholesterol) | 0.2 | -0.2 | |
hyperglycemia | 0.6 | 0.5 | 0.2 |
Hyperlipidemia (High Blood Fats) | 0.5 | 0.5 | |
hypertension (High Blood Pressure | 1.3 | 1.6 | -0.23 |
Hypothyroidism | 0.5 | -0.5 | |
Hypoxia | 0.6 | -0.6 | |
IgA nephropathy (IgAN) | 0.8 | 0.5 | 0.6 |
Inflammatory Bowel Disease | 1.8 | 1.8 | 0 |
Insomnia | 1.5 | 0.6 | 1.5 |
Intelligence | 0.2 | -0.2 | |
Intracranial aneurysms | 0.8 | -0.8 | |
Irritable Bowel Syndrome | 2 | 2.9 | -0.45 |
Juvenile idiopathic arthritis | 0.3 | 0.3 | |
Liver Cirrhosis | 1.1 | 1.1 | 0 |
Long COVID | 4.3 | 3.4 | 0.26 |
Lung Cancer | 0.8 | 0.2 | 3 |
ME/CFS with IBS | 0.6 | 0.5 | 0.2 |
ME/CFS without IBS | 0.6 | 0.5 | 0.2 |
Menopause | 0.9 | 0.4 | 1.25 |
Metabolic Syndrome | 3.3 | 3.7 | -0.12 |
Mood Disorders | 4.5 | 4.7 | -0.04 |
Multiple Sclerosis | 2.4 | 0.6 | 3 |
Multiple system atrophy (MSA) | 0.5 | 0.7 | -0.4 |
Neuropathy (all types) | 0.5 | -0.5 | |
neuropsychiatric disorders (PANDAS, PANS) | 0.3 | 0.6 | -1 |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.6 | 2.1 | -2.5 |
NonCeliac Gluten Sensitivity | 0.5 | -0.5 | |
Obesity | 2.4 | 2 | 0.2 |
obsessive-compulsive disorder | 0.6 | 2.1 | -2.5 |
Osteoarthritis | 0.3 | 0.8 | -1.67 |
Osteoporosis | 0.9 | 0.6 | 0.5 |
Parkinson's Disease | 2.5 | 0.4 | 5.25 |
Polycystic ovary syndrome | 1.6 | -1.6 | |
Postural orthostatic tachycardia syndrome | 0.5 | -0.5 | |
Premenstrual dysphoric disorder | 0.5 | 0.5 | |
primary biliary cholangitis | 0.2 | 0.2 | |
Psoriasis | 1.1 | 0.5 | 1.2 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 2.7 | 1.9 | 0.42 |
Rosacea | 0.8 | 0.8 | |
Schizophrenia | 1.5 | 2.8 | -0.87 |
Sjögren syndrome | 1 | 1.3 | -0.3 |
Sleep Apnea | 1.4 | 0.3 | 3.67 |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.3 | 0.2 | 0.5 |
Stress / posttraumatic stress disorder | 1.6 | 1.1 | 0.45 |
Systemic Lupus Erythematosus | 1.1 | 1.9 | -0.73 |
Tic Disorder | 0.2 | 1 | -4 |
Tourette syndrome | 0.6 | 0.6 | |
Type 1 Diabetes | 0.2 | 2.2 | -10 |
Type 2 Diabetes | 3.5 | 3 | 0.17 |
Ulcerative colitis | 3.9 | 1.6 | 1.44 |
Unhealthy Ageing | 1.5 | -1.5 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.